Is spevigo an iv injection?

Spevigo is given as an intravenous infusion.

Is spevigo a one-time treatment or does it require repeated doses?

Spevigo is administered as a single 900 mg dose by intravenous infusion. A second 900 mg dose may be given one week later if symptoms persist. No ongoing maintenance schedule is required.

How long does the spevigo infusion take?

Each infusion is delivered over 90 minutes. Patients are monitored for at least one hour after the infusion ends.

How is spevigo supplied and prepared?

Spevigo comes in single-dose vials containing 450 mg/7.5 mL of spesolimab-sbzo concentrate. The required volume is diluted in 0.9% sodium chloride before infusion.

What are the most common side effects reported with spevigo?

Injection-site reactions, fatigue, nausea, headache, and pruritus are the reactions listed most often in clinical data.

When does spevigo patent protection end?

The U.S. composition-of-matter patent for spesolimab expires in 2037. [1]

Who manufactures spevigo?

Boehringer Ingelheim manufactures and markets spevigo.

How does spevigo compare with other treatments for generalized pustular psoriasis?

Unlike traditional systemic agents such as cyclosporine or retinoids, spevigo targets interleukin-36 receptor signaling directly, offering a more specific mechanism with a shorter treatment course.

Can patients self-administer spevigo at home?

Spevigo must be given by a healthcare professional in a clinical setting; it is not approved for self-injection or home use.

1. https://www.drugpatentwatch.com/drug/spevigo